Flanagan-Uusitalo v. D.T. Industries, Inc.

190 F. Supp. 2d 105, 2001 U.S. Dist. LEXIS 23034, 2001 WL 1805333
CourtDistrict Court, D. Massachusetts
DecidedDecember 20, 2001
DocketCIV.A.99-40001-NMG
StatusPublished
Cited by10 cases

This text of 190 F. Supp. 2d 105 (Flanagan-Uusitalo v. D.T. Industries, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Flanagan-Uusitalo v. D.T. Industries, Inc., 190 F. Supp. 2d 105, 2001 U.S. Dist. LEXIS 23034, 2001 WL 1805333 (D. Mass. 2001).

Opinion

MEMORANDUM AND ORDER

GORTON, District Judge.

Following a number of adverse employment actions, plaintiff, Donna Flanagan-Uusitalo (“Flanagan”), filed suit against defendants, D.T. Industries, Inc., Pharma Group, Inc. and Lakso Company, in Massachusetts state court, alleging 1) sex discrimination, 2) handicap discrimination and 3) retaliation in violation of the Massachusetts discrimination statute, M.G.L. c. 151B. On January 4, 1999, the defendants removed the case to this Court on diversity grounds and, more recently, have filed the pending motion for summary judgment (Docket No. 37).

I. Factual Background

For purposes of this motion for summary judgment only, the facts are stated as alleged by the plaintiff, non-moving party-

Defendant D.T. Industries (“DTI”) is a publicly held corporation organized into three groups of companies: the Packaging Group, the Automation Group and the Components Group. The first of those groups does business as Pharma Group, *108 Inc. (“Pharma”) and is a wholly-owned subsidiary of defendant DTI. Pharma is engaged in the manufacture of processing and packaging systems primarily for the pharmaceutical industry. In February of 1995, Pharma acquired defendant Lakso Company (“Lakso”) and has since operated Lakso’s Leominster, Massachusetts facility as an unincorporated division. Pharma has three additional unincorporated divisions: Stokes-Merrill Co., Kalish Co. and Swiftpak Co. See Corporate Structure Diagram attached to this Memorandum & Order.

Plaintiff Flanagan was employed by Lakso as its “Accounting Manager” from 1983 until its acquisition by DTI/Pharma after which her title was changed to “Controller.” During the acquisition of Lakso, she was exposed to a sexually hostile work environment. Specifically, she claims that Steve Gore, President of DTI, and Joe Mallee, President of Stokes-Merrill, made comments that Flanagan was being reviewed by corporate personnel on the basis of her gender and her appearance and that comments were made that she was sleeping with her boss at Lakso. Flanagan expressed her concerns to both Mallee and Stan Burd, Corporate Controller for Phar-ma, but was advised that “this was the way the company operated.”

In September 1996, Flanagan interviewed for the newly created the position of Packaging Group Controller for Phar-ma. The position reported to both Burd and Graham Lewis, Packaging Group President. She was selected for the position over the objections of Lewis. Her annual salary was increased from $60,000 to $66,000 and she was entitled to a bonus based upon Pharma’s success. Flanagan later learned that similarly-situated male controller who reported to her received a comparable, if not higher, salary. Flanagan’s responsibilities as Packaging Group Controller included supervising the controllers of Pharma’s unincorporated divisions but she also continued to perform her duties as Controller for Lakso.

Flanagan claims that, during her interview for Group Controller, Lewis made inappropriate comments about her style of dress and the manner in which she crossed her legs. During a business meeting in November of 1996, Lewis subjected Flanagan to discriminatory remarks. In front of her colleagues, he commented that she and a co-worker were “lovebirds.” He also stated, at that same meeting, that she would not be successful as Group Controller because she was weak and would not be able to control the male employees.

In February of 1997, Flanagan suffered a heart attack. Prior to her official return to work, she performed work at home. Flanagan applied for and received short-term disability benefits through DTI’s short-term disability program. At no time was she required to provide a medical verification of her heart attack or a return-to-work authorization. For approximately six weeks following her return to work, she attended cardiovascular rehabilitation three times per week.

During her recuperation and after returning to work in April, 1997, both Lewis and Burd directed Flanagan to focus on the Lakso Controller position and less on the new Group Controller position. Flanagan resumed the air travel required as part of the Group Controller job in May, 1997.

In September of 1997, unbeknownst to Flanagan, DTI’s Vice President of Finance decided to reorganize the Finance Department because the current management structure was no longer feasible due to the large number of subsidiaries. Accordingly, the position of Packaging Group Vice President of Administration was created to assume most of Burd’s supervisory duties *109 as Corporate Controller with respect to the Packaging Group. Both the Corporate Controller and the Packaging Group Controller positions were therefore eliminated.

Notwithstanding the elimination of the Group Controller position, Flanagan continued to perform both her Lakso Controller and Group Controller duties through January, 1998. At that time, she first learned that the Group Controller position had been eliminated pursuant to the 1997 corporate reorganization. She also learned that DTI and Pharma had hired Jerome Kroll for the newly created Packaging Group Vice President of Administration. That position subsumed many, if not all, of her duties and reporting relationships as Group Controller. Despite the elimination of the Group Controller position, Flanagan’s salary was not decreased.

In late 1997 or January, 1998, Jerry Scheminger was hired or transferred in to become the Vice President of Operations for Lakso, a position which had been vacant. Lewis had previously asked Flanagan to consider assuming responsibility for running the Lakso facility, but, although she expressed an interest in doing so, she was never interviewed or even informed that Defendants were recruiting for the Vice President of Operations position or that the position was available.

Flanagan received a bonus in 1997 for the preceding fiscal year which was inconsistent with her responsibilities as Group Controller. Rather, it was more in line with her duties as Lakso Controller. Other Group Controllers allegedly received much larger bonuses. When she questioned Lewis about the bonus, he indicated that it was reflective of her illness and not doing the Group Controller’s job.

On February 17, 1998, Flanagan filed a complaint with the Massachusetts Commission Against Discrimination (“MCAD”), alleging sexual harassment, sex discrimination and handicap discrimination. Since filing the MCAD complaint, Flanagan claims that her performance is “overly scrutinized” and that she is not consulted about important company issues.

In accordance with company policy and supported by medical documentation, Flanagan again obtained short-term disability benefits in May, 1998. On June 29, 1998, she received correspondence from Human Resources (“HR”) indicating that she would henceforth be required to furnish additional documentation to support her continuation on the disability plan. No deadline was provided nor any indication given that her compensation under the plan would immediately cease.

On July 7, 1998, Flanagan was informed that her disability coverage was cancelled and that she would receive no further payments under the disability plan until satisfactory medical documentation was received.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Consedine v. Willimansett East SNF
213 F. Supp. 3d 253 (D. Massachusetts, 2016)
Robinson v. District of Columbia
130 F. Supp. 3d 180 (District of Columbia, 2015)
Shervin v. Partners Healthcare System, Inc.
2 F. Supp. 3d 50 (D. Massachusetts, 2014)
Kelly v. Cort Furniture
717 F. Supp. 2d 120 (D. Massachusetts, 2010)
Newell v. Celadon Security Services, Inc.
417 F. Supp. 2d 85 (D. Massachusetts, 2006)
Cornwell v. Dairy Farmers of America, Inc.
369 F. Supp. 2d 87 (D. Massachusetts, 2005)
Burton v. Batista
339 F. Supp. 2d 97 (District of Columbia, 2004)
Ritchie v. Department of State Police
805 N.E.2d 54 (Massachusetts Appeals Court, 2004)
Lester v. Natsios
290 F. Supp. 2d 11 (District of Columbia, 2003)
Brissette v. Franklin County, Sheriff's Office
235 F. Supp. 2d 63 (D. Massachusetts, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
190 F. Supp. 2d 105, 2001 U.S. Dist. LEXIS 23034, 2001 WL 1805333, Counsel Stack Legal Research, https://law.counselstack.com/opinion/flanagan-uusitalo-v-dt-industries-inc-mad-2001.